Drug makers may profit from disease in global warming scourge

onJun 14, 2007 @ 10:25 PDT

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

By Bill Miller

Amsterdam Defies Last-Minute Lobbying to Become First Capital City to Ban Fossil Fuel Ads

ByEllen Ormesher

onJan 23, 2026 @ 09:43 PST

The world’s largest outdoor advertising company warned city councillors of “far-reaching consequences” hours before the landmark vote.

After Decades of Deflection, ExxonMobil Moves to Reshape Global Climate Accounting

BySharon Kelly

onJan 23, 2026 @ 09:12 PST

For decades, ExxonMobil argued consumers, not oil giants, should take responsibility for fossil fuel pollution. It’s now backing Carbon Measures’ accounting scheme, which moves pollution “liabilities” to buyers’ books.